2001
DOI: 10.1016/s0002-9440(10)63994-6
|View full text |Cite
|
Sign up to set email alerts
|

Histopathological Identification of Colon Cancer with Microsatellite Instability

Abstract: and the Eastern Cooperative Oncology Group, ‡ Brookline, MassachusettesCancer with high levels of microsatellite instability (MSI-H) is the hallmark of hereditary nonpolyposis colorectal cancer syndrome, and MSI-H occurs in ϳ15% of sporadic colorectal carcinomas that have improved prognosis. We examined the utility of histopathology for the identification of MSI-H cancers by evaluating the features of 323 sporadic carcinomas using specified criteria and comparing the results to MSI-H status. Coded hematoxylin … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

22
326
6
10

Year Published

2004
2004
2015
2015

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 450 publications
(364 citation statements)
references
References 49 publications
22
326
6
10
Order By: Relevance
“…12,32 However, immunohistochemistry cannot replace testing for microsatellite instability to identify microsatellite-unstable sporadic colorectal cancer, 33 and morphological prediction of microsatellite-unstable cancer has low sensitivity. 34 Thus, we emphasize that both hMLH1 immunohistochemistry and a histopathological evaluation can predict medullary-type carcinomas, but they may miss some cases. 32,33 Molecular analysis is required for therapeutic decisions.…”
Section: Discussionmentioning
confidence: 90%
See 1 more Smart Citation
“…12,32 However, immunohistochemistry cannot replace testing for microsatellite instability to identify microsatellite-unstable sporadic colorectal cancer, 33 and morphological prediction of microsatellite-unstable cancer has low sensitivity. 34 Thus, we emphasize that both hMLH1 immunohistochemistry and a histopathological evaluation can predict medullary-type carcinomas, but they may miss some cases. 32,33 Molecular analysis is required for therapeutic decisions.…”
Section: Discussionmentioning
confidence: 90%
“…32,33 Molecular analysis is required for therapeutic decisions. 34 Colorectal adenocarcinoma are graded predominantly on the basis of the extent of glandular appearances. 2,3 They are divided into well, moderately, and poorly differentiated, and in general the differentiation may reflect a biological behavior.…”
Section: Discussionmentioning
confidence: 99%
“…Analysis of K-ras, APC, and b-catenin gene mutation was carried out as previously described. 5 Immunohistochemistry for microsatellite analysis of markers hMLH1 and hMSH2 was carried out according to the method of Alexander et al 18 Immunohistochemistry for p53 protein was also performed according to previously published method. 19 Overexpression of p53 protein was considered to be present when more than 50% of the nuclei of tumor cells were strongly stained.…”
Section: Molecules Analysesmentioning
confidence: 99%
“…Th is phenotype can be assayed using either polymerase chain reaction polymerase chain reaction-based methods or immunohistochemistry for loss of MLH1 mismatch repair protein expression. Sporadic MSI + tumors occur more frequently proximal to the splenic fl exure and tend to show poor diff erentiation, mucinous histology and increased peritumoral lymphocytic infi ltration ( 4 ). Th ese tumors usually have near-diploid karyotypes and harbor a distinct set of driver mutations in genes such as BRAF and TGFBR2 ( 5,6 ).…”
Section: Introductionmentioning
confidence: 99%